AILIS is a pioneering technology. It combines Dynamic Parametric Imaging, artificial intelligence, and telemedicine to immediately detect symptoms of breast cancer and estimate the risk of developing the disease.
Thanks to AI
Thanks to telemedicine
Thanks to DPI
How it's working
See the cancer before it develops
Breast tissue in which cancer is developing or has already developed has a noticeably different level of metabolism and blood supply. By comparing both breasts, we get a clear and unambiguous image of any, even if only potential, anomalies. It’s a super-precise technology that has potential to allows diagnosis at a stage when mammography is still completely helpless.
Artificial intelligence, real results
Diagnosis results are analyzed in real time thanks to using advanced artificial intelligence algorithms.
Using AI minimizes the possibility of incorrect diagnosis. This is because human factors are limited, which is a breakthrough for the future, especially considering the rapidly decreasing numbers of radiology experts.
A neural network - every woman is most important
Advanced algorithms analyze thousands of breast testing results, learning to recognize and differentiate between healthy and ill tissues. This is why artificial intelligence is capable of detecting even the slightest symptoms of anomalies and predict the possibility of their occurrence at a specific time.
The system learns about the breasts of a particular woman, learns its structure, and develops an individual monitoring plan that allows for adjusting the frequency of testing to the needs of a particular woman.
Telemedicine - when minutes count
For women the most difficult part of screening is waiting for the results. Thanks to AILIS, this problem will be eliminated.
An AILIS test, including getting the results, takes only 15 minutes. What is more, a woman will be able to remotely consult every worrying symptom with a radiologist within only 48 hours.
Cancer does not wait, now we can outrun it.
Our application - quick and on the spot
A simple an well though-out application will enable quick registration, immediate review of test results, contact with specialists, and development of an individual breast monitoring plan.
Currently, we are at the stage of meeting the requirements of market regulators and preparing for clinical research to obtain the necessary medical certificates.